Proteins having pneumococcal capsule degrading activity and methods of use
AssigneeUniversity of Georgia Research Foundation, Inc.
InventorsFikri Y. Avci, Dustin Middleton, Amy Victoria Paschall
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Georgia Research Foundation, Inc.
InventorsFikri Y. Avci, Dustin Middleton, Amy Victoria Paschall
Estimating the term…
Provided herein is a protein, referred to as a Pn3Pase protein, that degrades the capsular polysaccharide of serotype 3 Streptococcus pneumoniae. The disclosure includes a genetically modified cell that includes a Pn3Pase protein, and compositions that include the protein, the polynucleotide encoding the protein, the genetically modified cell, or a combination thereof. Also provided are methods for using a Pn3Pase protein, including methods for contacting a S. pneumoniae having a type III capsular polysaccharide with a Pn3Pase protein, increasing deposition of at least one complement component on the surface of a S. pneumoniae, treating an infection in a subject, treating a symptom in a subject, decreasing colonization of a subject by S. pneumoniae, or a combination thereof.
A genetically modified cell comprising a mature Pn3Pase protein, wherein the protein has Pn3Pase activity, wherein the cell comprises an exogenous polynucleotide comprising a coding region encoding a Pn3Pase protein.
A genetically modified cell comprising a polynucleotide comprising a coding region, wherein the coding region comprises a nucleotide sequence encoding a mature Pn3Pase protein, wherein the protein has Pn3Pase activity, and wherein the protein comprises a heterologous amino acid sequence.
Dependencies are inferred from the claim text.